Intimation about closure of Trading Window for Q ended 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sandu Pharmaceuticals has informed the exchange that its trading window for dealing in company shares will be closed for the quarter ending 31st March 2026. This is a standard insider-trading compliance practice under SEBI rules, typically invoked ahead of the announcement of financial results so that insiders (directors, officers, auditors, employees) do not trade while in possession of unpublished price-sensitive information. The window usually reopens 48 hours after the audited/un-audited results are made public. Note: the actual BSE filing page was not accessible (page moved/error), so details on the exact window open/close dates and the reason cited are not available in the source.
No direct impact on shareholders or stock price — this is a routine regulatory disclosure and does not signal any corporate action, earnings surprise, or insider activity. Investors should just watch for the upcoming Q4 FY26 results announcement, which is likely to follow shortly after the window reopens.